Bloomberg Surveillance TV: May 14, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Piper Sandler Reduces PT on lululemon athletica (LULU) Stock
lululemon athletica inc. (NASDAQ:LULU) is one of the Reddit Stocks with the Highest Upside Potential. On July 29, Piper Sandler reduced the price target on the company's stock to $200 from $270, while keeping a 'Neutral' rating, as reported by The Fly. As per the firm, the fall in lululemon athletica inc. (NASDAQ:LULU)'s shares this year was because of a correction in the multiple. In Q1 2025, the company achieved growth throughout its channels, categories, and markets, including the US, demonstrating the continued strength and agility of its business model. A store employee in an athletic apparel store restocking merchandise. Amidst the dynamic macro environment, lululemon athletica inc. (NASDAQ:LULU) plans to leverage its robust financial position and competitive advantages to play offense, while it continues to invest in growth opportunities. In Q1 2025, its net revenue rose 7% to $2.4 billion, or 8% on a constant dollar basis, with the Americas net revenue rising 3% and the International net revenue increasing 19%. For Q2 2025, lululemon athletica inc. (NASDAQ:LULU) anticipates net revenue of between $2.535 billion – $2.560 billion, reflecting growth of 7% – 8%. RGA Investment Advisors, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'Late in the quarter, we purchased shares in Lululemon athletica inc. (NASDAQ:LULU), despite uncertainty about the tariff situation. Many of you are familiar with the brand. Lulu is a leading athleisure brand and though competition has increased from upstart offerings like Vuori, Alo and Fabletics, the company has continued to maintain relevance and perform admirably. These upstarts have varied approaches, but in aggregate, they have won share with a combination of faster, more tasteful fashion and cheaper prices. Importantly, this share has predominantly come from Nike–the 10,000 pound gorilla of the industry that continues to see negative topline growth. Even within the competitive landscape, it is notable that Vuori and Alo enthusiasts still consider Lulu core to their wardrobe, given the demonstrable quality advantage of the company's proprietary fabrics. Although Lulu has benefited from dominance in fashion, its core calling has been performance and that segment of the market remains unquestioned. While we acknowledge the potential of LULU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
30 minutes ago
- Yahoo
Novo Nordisk A/S (NVO) Delivers 18% Sales Growth in H1 2025
Novo Nordisk A/S (NYSE:NVO) is one of the Reddit Stocks with the Highest Upside Potential. On August 6, the company stated that it delivered 18% sales growth in H1 2025. The company has lowered its full-year outlook because of lower growth expectations for its GLP-1 treatments in H2 2025. Therefore, it has been taking measures to sharpen its commercial execution further, and ensure efficiencies in its cost base while continuing to make investments in future growth. With over 1 billion people living with obesity globally, which includes over 100 million living in the US, and only a few million on treatment, Novo Nordisk A/S (NYSE:NVO) expects to maximise the strong growth opportunities, thanks to the healthy product portfolio and future pipeline. A closeup shot of a laboratory technician handling a medical device used for fertility treatments. Novo Nordisk A/S (NYSE:NVO) highlighted that the sales within Diabetes and Obesity care rose 16% in Danish kroner to DKK 145.4 billion (and 18% at CER), mainly due to the Obesity care growth of 56% in Danish kroner to DKK 38.8 billion (and 58% at CER) and GLP-1 diabetes sales increasing 8% in Danish kroner (10% at CER). Within R&D, Novo Nordisk A/S (NYSE:NVO) plans to advance subcutaneous and oral amycretin into phase 3 development in weight management on the basis of completed clinical studies during Q1 2025. For FY 2025, the sales growth is anticipated to be 8% – 14% at CER, and operating profit growth is projected to be 10% – 16% at CER. ClearBridge Investments, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'We initiated a new position in Novo Nordisk A/S (NYSE:NVO), the global leader in diabetes care and one of two dominant players in the fast-growing GLP-1 diabetes and obesity drug market. A slowdown in prescriptions for Novo's GLP-1 drugs, combined with confusion surrounding a clinical trial of its next-generation candidate, CagriSema, caused a significant pullback in the stock. We saw this as a buying opportunity. We believe the GLP-1 market remains vast and that Novo (alongside Eli Lilly) is well-positioned to maintain a duopolistic structure for years to come, given the complexity of manufacturing, differentiated intellectual property and brand strength. We also expect growth to reaccelerate as supply ramps up following its acquisition of Catalent and as regulators crack down on unlicensed compounders.' While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
Bank of America Securities Reiterates Buy Rating on Crocs (CROX) Stock
Crocs, Inc. (NASDAQ:CROX) is one of the Reddit Stocks with the Highest Upside Potential. On August 8, Bank of America Securities analyst Christopher Nardone reiterated a 'Buy' rating on the company's stock and set a price objective of $99.00. The analyst's rating is backed by a combination of factors demonstrating potential for future growth amidst the current challenges. As per the analyst, while Q3 2025 guidance was disappointing, there remains an optimistic outlook for Crocs, Inc. (NASDAQ:CROX)'s fundamentals to witness improvement beyond this period. A busy retail store full of customers trying on a wide range of footwear. Furthermore, the international segment demonstrated a promising growth in Q2 2025, and the analyst opines that a low double-digit growth rate remains achievable in the upcoming quarters. Even though there are short-term pressures due to the tariffs and changes in product mix, the analyst opines that the gross margin is expected to stay strong because of Crocs, Inc. (NASDAQ:CROX)'s emphasis on controlling promotions. This strategic approach is expected to support a healthy FCF profile, added Nardone. While North American sales are projected to encounter challenges, the analyst anticipates gradual improvement on the back of new product innovations as well as strategic adjustments to offset tariff impacts. Artisan Partners, an investment management company, released its Q4 2024 investor letter. Here is what the fund said: 'Among our top detractors were Halozyme, Crocs, Inc. (NASDAQ:CROX) and Novanta. Crocs designs, develops, manufactures and distributes casual footwear and accessories for men, women and children. The company invented the molded plastic clog in 2002 and turned it into a multibillion-dollar (USD) global revenue producer. We believe expansion opportunities outside the US, demand from new product introductions (including from recently acquired Hey Dude) and distribution pushes within the direct-to-consumer and wholesale channels will drive greater-than-expected revenue growth. We had expected the performance of its HeyDude brand to have already bottomed, but forward guidance continues to indicate its turnaround efforts, driven by a new divisional leader, will take longer than expected. We maintained our position as we believe the market underappreciates the longer term profit cycle.' While we acknowledge the potential of CROX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
